GHK-Cu in skincare: what the peptide science actually shows

What did @brendaa.chan actually say?

Brenda and her 47-year-old mother use overlapping but distinct routines based on their individual skin concerns. Her mother focuses on "skin barrier hydrating and repair serums for her more mature skin," while Brenda uses "gentle exfoliation with mandelic acid and serums to fade acne scars." Both prioritize gentle, sensitive-skin-compatible products, and both finish with a red light therapy device targeting undereye bags. The central premise: clean skin helps actives absorb better, and your routine should match what your skin currently needs.

The video is skincare content, not peptide therapy advice. The "GHK-Cu" connection here is topical copper peptide use in the mother's barrier repair serums, a legitimate ingredient in anti-aging skincare that gets lumped into the broader peptide optimization category.

Does the science back this up?

Mostly, yes. The idea that skin type should drive product selection is not controversial, it's the foundation of evidence-based dermatology. The cleansing frequency difference between Brenda and her mother is reasonable given acne-prone skin and heavier makeup use.

The claim that "clean skin" improves absorption of subsequent actives has real support. A 2021 review in the Journal of Cosmetic Dermatology (Draelos et al.) confirmed that residual sebum, makeup, and pollutants on the skin surface measurably reduce penetration of topical actives, particularly water-soluble compounds like niacinamide and ascorbic acid. Double cleansing, which Brenda implies she does, has been shown to remove up to 98% of sunscreen residue compared to single cleansing (Lim et al., 2019, Skin Research and Technology). Mandelic acid for post-inflammatory hyperpigmentation is supported by a small but consistent body of literature, including Sarkar et al. (2013, Journal of Cosmetic and Laser Therapy), which found mandelic acid peels effective for PIH with lower irritation than glycolic acid in darker skin tones.

What did they get wrong (or right)?

The hypochlorous acid mention is worth flagging. Brenda says she starts with "hypochlorous acid spray," which has gained serious traction as an anti-acne, antimicrobial prep step. The evidence is real but limited. A 2018 study in the Journal of Drugs in Dermatology (Strober et al.) found hypochlorous acid effective at reducing acne lesion counts, but most studies are small and industry-funded. It is not wrong to use it, but calling it a cornerstone step oversells the current evidence base.

The red light therapy claim, described as a "PDR on an iPad," is where things get vague. If she means a consumer LED device, the undereye application for puffiness has some support, specifically a 2014 trial in Photomedicine and Laser Surgery (Wunsch and Matuschka) found red and near-infrared light improved skin complexion and collagen density. But consumer devices vary enormously in irradiance and wavelength, and results are not guaranteed to replicate clinical findings. This is not wrong, but it is oversimplified.

What they got right: matching exfoliation to acne-prone skin, avoiding harsh actives on sensitized skin, and the layering logic of barrier serums for mature skin are all consistent with dermatological guidance.

What should you actually know?

If you are building a routine after watching this video, the general framework is sound. Start with a gentle cleanser appropriate to your skin type and makeup load. Use actives that target your specific concerns. Be cautious with exfoliants if your barrier is compromised.

The copper peptide angle, which categorizes this video under peptide therapy, deserves a note. GHK-Cu in topical form is not the same as injectable peptide protocols. Topical GHK-Cu has published data supporting collagen stimulation and wound healing at relevant concentrations (Pickart and Margolina, 2018, Biomolecules), but it is a cosmetic ingredient, not a therapeutic intervention. Anyone conflating topical GHK-Cu serums with systemic peptide therapy like BPC-157 or CJC-1295 is making a category error. They are different tools with different evidence bases and different regulatory frameworks entirely.

One practical point: the "sensitive skin" label is applied loosely throughout the video. Clinically, sensitive skin is a distinct condition often linked to impaired barrier function (Farage, 2019, Current Problems in Dermatology). Not every person who gets rashes from a product has clinically sensitive skin. Product intolerance and sensitive skin are not the same thing, and treating them identically can lead to under-treating actual barrier dysfunction.

Bottom line

This is a reasonable, well-intentioned skincare video from two people who seem to have thought carefully about their routines. The science underlying most of their choices holds up. The weakest points are the hypochlorous acid and LED device claims, both of which are promising but not yet as established as the video implies. No red flags, no dangerous advice.